10x wins injunction from unified patent court banning sales of nanostring's cosmx products in europe

Second injunction issued against cosmx pleasanton, calif. , sept. 19, 2023 /prnewswire/ -- 10x genomics, inc. (nasdaq: txg), a leader in single cell and spatial biology, announced today that the european unified patent court ("upc") issued a preliminary injunction against nanostring technologies, inc. (nasdaq: nstg) for infringing european patent 4 108 782 b1 ("the ep 782 patent," docket no 459746/2023).
NSTG Ratings Summary
NSTG Quant Ranking